Proteome Sciences plc

AIM:PRM Voorraadrapport

Marktkapitalisatie: UK£8.1m

Proteome Sciences Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Mariola Sohngen

Algemeen directeur

UK£261.0k

Totale compensatie

Percentage CEO-salaris95.4%
Dienstverband CEO4.2yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn7.3yrs
Gemiddelde ambtstermijn bestuur7.3yrs

Recente managementupdates

Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

May 10
Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

Recent updates

Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

May 10
Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

Here's Why We Think Proteome Sciences (LON:PRM) Is Well Worth Watching

Dec 02
Here's Why We Think Proteome Sciences (LON:PRM) Is Well Worth Watching

Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Aug 25
Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Dec 22
Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Do Proteome Sciences' (LON:PRM) Earnings Warrant Your Attention?

Sep 03
Do Proteome Sciences' (LON:PRM) Earnings Warrant Your Attention?

Calculating The Fair Value Of Proteome Sciences plc (LON:PRM)

Jan 27
Calculating The Fair Value Of Proteome Sciences plc (LON:PRM)

Does Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?

May 31
Does Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?

Some Confidence Is Lacking In Proteome Sciences plc's (LON:PRM) P/E

Apr 04
Some Confidence Is Lacking In Proteome Sciences plc's (LON:PRM) P/E

Analyse CEO-vergoeding

Hoe is Mariola Sohngen's beloning veranderd ten opzichte van Proteome Sciences's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-UK£4m

Mar 31 2024n/an/a

-UK£3m

Dec 31 2023UK£261kUK£249k

-UK£2m

Sep 30 2023n/an/a

-UK£879k

Jun 30 2023n/an/a

UK£684k

Mar 31 2023n/an/a

UK£1m

Dec 31 2022UK£310kUK£247k

UK£1m

Sep 30 2022n/an/a

UK£943k

Jun 30 2022n/an/a

UK£560k

Mar 31 2022n/an/a

UK£316k

Dec 31 2021UK£258kUK£235k

UK£72k

Sep 30 2021n/an/a

UK£228k

Jun 30 2021n/an/a

UK£384k

Mar 31 2021n/an/a

UK£340k

Dec 31 2020UK£252kUK£73k

UK£295k

Compensatie versus markt: De totale vergoeding ($USD 328.74K ) Mariola } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 356.31K ).

Compensatie versus inkomsten: De vergoeding van Mariola is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Mariola Sohngen (63 yo)

4.2yrs

Tenure

UK£261,000

Compensatie

Dr. Mariola Sohngen serves as Chief Executive Officer and Executive Director at Proteome Sciences plc since September 15, 2020. Dr. Söhngen served as a Member of the Executive Board of Mologen AG since Nov...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Mariola Sohngen
CEO & Executive Director4.2yrsUK£261.00kgeen gegevens
Abdelghani Omari
CFO & Director2.2yrsUK£212.00kgeen gegevens
Ian Pike
Chief Scientific Officer & Executive Director7.9yrsUK£245.00k0.056%
£ 4.6k
Richard Dennis
Chief Commercial Officer & Executive Director7.6yrsUK£207.00k0.21%
£ 17.2k
Victoria Birse
Company Secretary7.3yrsgeen gegevensgeen gegevens

7.3yrs

Gemiddelde duur

61.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van PRM is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.3 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Mariola Sohngen
CEO & Executive Director4.2yrsUK£261.00kgeen gegevens
Abdelghani Omari
CFO & Director2.2yrsUK£212.00kgeen gegevens
Ian Pike
Chief Scientific Officer & Executive Director14.1yrsUK£245.00k0.056%
£ 4.6k
Richard Dennis
Chief Commercial Officer & Executive Director6.6yrsUK£207.00k0.21%
£ 17.2k
Denis Hochstrasser
Member of the Scientific Advisory Boardno datageen gegevensgeen gegevens
Christopher Donovan Pearce
Non Executive Chairman30.3yrsUK£62.00k12.51%
£ 1.0m
Roger McDowell
Independent Non Executive Director10.3yrsUK£35.00k1.15%
£ 93.5k
William Dawson
Chairman of Scientific Advisory Boardno dataUK£16.00kgeen gegevens
Jean-Charles Sanchez
Member of the Scientific Advisory Boardno datageen gegevensgeen gegevens
Brian Anderton
Member of the Scientific Advisory Boardno datageen gegevensgeen gegevens
Ursula Ney
Independent Non-Executive Director7.3yrsUK£33.00kgeen gegevens
Julian Duncan
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens

7.3yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van PRM wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.3 jaar).